Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin C

Keyphrases

• Adult Patients 100%
• Baseline Serum Creatinine 20%
• Chronic Kidney Disease Epidemiology Collaboration Equation 40%
• Clinical Evaluation 20%
• Cockcroft-Gault 20%
• Cockcroft-Gault Equation 20%
• Creatinine 80%
• Creatinine Clearance 40%
• Creatinine Excretion 20%
• Creatinine Measurement 20%
• Cystatin C (Cys C) 100%
• Denervation 20%
• Disease-related Proteins 20%
• Drug Dosing 40%
• Equation-based 20%
• Estimated Glomerular Filtration Rate 40%
• Glomerular Filtration Rate 60%
• Inactivity 20%
• Kidney Function 20%
• Kidney Injury 100%
• Lean Body Mass 100%
• Low muscle Mass 20%
• Medication Dosing 100%
• Muscle Atrophy 40%
• National Kidney Foundation 20%
• Patients with Liver Disease 20%
• Protein-energy Malnutrition 20%
• Serum Creatinine 20%
• Serum Creatinine Concentration 20%
• Serum Creatinine Level 20%
• Weight Loss 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Kidney Failure 20%
• Clinical Trial 10%
• Creatinine 100%
• Cystatin C 100%
• Kidney Injury 100%
• Kwashiorkor 10%
• Liver Disease 10%
• Muscle Atrophy 20%